244 related articles for article (PubMed ID: 22571402)
1. Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Lalatsa A; Garrett NL; Ferrarelli T; Moger J; Schätzlein AG; Uchegbu IF
Mol Pharm; 2012 Jun; 9(6):1764-74. PubMed ID: 22571402
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Siew A; Le H; Thiovolet M; Gellert P; Schatzlein A; Uchegbu I
Mol Pharm; 2012 Jan; 9(1):14-28. PubMed ID: 22047066
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.
Kanwal U; Bukhari NI; Rana NF; Rehman M; Hussain K; Abbas N; Mehmood A; Raza A
Int J Nanomedicine; 2019; 14():1-15. PubMed ID: 30587981
[TBL] [Abstract][Full Text] [Related]
4. A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.
Lalatsa A; Lee V; Malkinson JP; Zloh M; Schätzlein AG; Uchegbu IF
Mol Pharm; 2012 Jun; 9(6):1665-80. PubMed ID: 22574705
[TBL] [Abstract][Full Text] [Related]
5. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.
Lalatsa A; Schätzlein AG; Garrett NL; Moger J; Briggs M; Godfrey L; Iannitelli A; Freeman J; Uchegbu IF
J Control Release; 2015 Jan; 197():87-96. PubMed ID: 25449808
[TBL] [Abstract][Full Text] [Related]
6. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
7. Physical characterisation and long-term stability studies on quaternary ammonium palmitoyl glycol chitosan (GCPQ)--a new drug delivery polymer.
Chooi KW; Simão Carlos MI; Soundararajan R; Gaisford S; Arifin N; Schätzlein AG; Uchegbu IF
J Pharm Sci; 2014 Aug; 103(8):2296-306. PubMed ID: 24916193
[TBL] [Abstract][Full Text] [Related]
8. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.
Serrano DR; Lalatsa A; Dea-Ayuela MA; Bilbao-Ramos PE; Garrett NL; Moger J; Guarro J; Capilla J; Ballesteros MP; Schätzlein AG; Bolás F; Torrado JJ; Uchegbu IF
Mol Pharm; 2015 Feb; 12(2):420-31. PubMed ID: 25558881
[TBL] [Abstract][Full Text] [Related]
9. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides.
Caban S; Capan Y; Couvreur P; Dalkara T
Methods Mol Biol; 2012; 846():321-32. PubMed ID: 22367822
[TBL] [Abstract][Full Text] [Related]
11. Strategies to deliver peptide drugs to the brain.
Lalatsa A; Schatzlein AG; Uchegbu IF
Mol Pharm; 2014 Apr; 11(4):1081-93. PubMed ID: 24601686
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
Mittal G; Carswell H; Brett R; Currie S; Kumar MN
J Control Release; 2011 Mar; 150(2):220-8. PubMed ID: 21111014
[TBL] [Abstract][Full Text] [Related]
13. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
14. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
15. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
16. Gut feelings: the potential of oral administration of therapeutic peptides to the brain.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):946. PubMed ID: 23019668
[No Abstract] [Full Text] [Related]
17. Quaternary ammonium palmitoyl glycol chitosan--a new polysoap for drug delivery.
Uchegbu IF; Sadiq L; Arastoo M; Gray AI; Wang W; Waigh RD; Schätzlein AG
Int J Pharm; 2001 Aug; 224(1-2):185-99. PubMed ID: 11472828
[TBL] [Abstract][Full Text] [Related]
18. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
Wong CY; Al-Salami H; Dass CR
J Drug Target; 2018 Aug; 26(7):551-562. PubMed ID: 29095650
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
20. Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.
Lerchbammer-Kreith Y; Hejl M; Sommerfeld NS; Weng-Jiang X; Odunze U; Mellor RD; Workman DG; Jakupec MA; Schätzlein AG; Uchegbu IF; Galanski MS; Keppler BK
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
